191
DNA Genes
143
RNA Fusion Genes
Actionable
Biomarkers
FFPE + FNA
TUMOR SPECIMENS
SNV, INDEL, CNV
& Gene Fusions

Designed for Actionable Oncology Testing

The FFPE Precision Oncology NGS Panel combines DNA mutation analysis and RNA transcript profiling in one integrated testing solution. Built around clinically actionable oncology markers, the panel helps laboratories reduce sequencing burden and streamline costs while maintaining the ability to detect known and novel fusion events.

Why DNA + RNA from FFPE and FNA?

FFPE tissue and fine needle aspirate (FNA) specimens are among the most common sample types used in solid tumor testing. This integrated panel enables laboratories to detect sequence-level DNA alterations alongside clinically relevant RNA fusions and transcript-level events from limited tumor material.

FNA compatibility is particularly valuable for lung cancer workflows, where limited specimen availability can make comprehensive molecular profiling more challenging.

✓ Clinically actionable mutations and fusions
✓ Known and novel fusion detection
✓ RNA transcript variants and exon-skipping events
✓ Reduced sequencing burden
✓ Efficient interpretation and reporting
✓ Optimized for FFPE and FNA specimens

DNA Mutation Panel

Detects clinically relevant DNA alterations across a broad range of cancer-associated genes.

191
TOTAL DNA GENES
107
TIER 1 & 2
84
TIER 3 & 4
SNVs
Single Nucleotide
Variants
Indels
Insertions &
Deletions
CNVs
Copy Number
Variations

RNA Fusion Panel

Advanced RNA analysis designed to identify clinically relevant fusion events and transcript-level alterations.

143
FUSION GENES
58
TIER 1 & 2
85
TIER 3 & 4
Gene Fusions
Known & novel
fusion events
Transcript Variants
Splice variants &
exon-skipping
RNA Variants
SNVs, indels &
expression changes

Partner-Agnostic RNA Fusion Detection

Detects known and novel fusion events without requiring predefined fusion partners or breakpoint assumptions. The RNA workflow also supports splice variants, exon-skipping events, RNA SNVs, indels, and gene-expression changes.

Also available as a standalone RNA Fusion Panel for laboratories with an established DNA workflow.

Explore the Standalone RNA Fusion Panel →

Advanced Fusion Detection Technology

Partner-agnostic RNA analysis enables detection of known, rare, and novel gene fusion events without requiring predefined fusion partners or breakpoint assumptions, while also supporting transcript-level variant detection.

Traditional Fusion Assays

  • Require predefined fusion partners
  • Depend on known breakpoint locations
  • May miss rare fusion events
  • Limited discovery potential

Our Partner-Agnostic Approach

  • Detects known and novel fusion events
  • Identifies rare fusion partners
  • Captures unexpected rearrangements
  • Supports splice variants and exon-skipping events
  • Expands actionable discovery opportunities

Why It Matters

Unlike conventional fusion assays that require prior knowledge of fusion partners or breakpoint locations, our RNA workflow supports detection of clinically relevant known and novel fusion events while providing broader transcript-level insight.

✓
Novel Fusions
✓
Rare Partners
✓
Structural Rearrangements
✓
Transcript-Level Insight

Variant Detection Capabilities

Detect multiple genomic alteration types critical for comprehensive oncology profiling from FFPE tumor samples.

DNA Alterations

SNVs
Single nucleotide variants
Indels
Insertions and deletions
CNVs
Copy number variations

RNA Alterations

Gene Fusions
Known and novel oncogenic fusion events
Transcript Variants
Splice variants and exon-skipping events
RNA SNVs & Indels
Transcript-level sequence variants

Position-Specific Error Detection

Position-specific error detection evaluates error patterns at individual genomic positions to help distinguish true low-frequency variants from background sequencing noise.

This supports improved sensitivity and specificity for more confident variant detection.

Request More Information

Interested in adding integrated DNA mutation and RNA fusion analysis to your oncology testing workflow? Complete the form below to request panel specifications, pricing, sample requirements, or information about platform compatibility and implementation support. A Jant representative will contact you to discuss your laboratory’s FFPE and FNA testing needs.

    Leave the box checked if you wish to receive occasional special offer emails, or uncheck it to decline. Don't worry, we won't spam you.